CSIMarket
 
Usana Health Sciences Inc   (USNA)
Other Ticker:  
 
 
Price: $48.9000 $-1.21 -2.415%
Day's High: $50.11 Week Perf: 0.37 %
Day's Low: $ 48.89 30 Day Perf: -1.55 %
Volume (M): 61 52 Wk High: $ 69.60
Volume (M$): $ 2,988 52 Wk Avg: $56.95
Open: $50.11 52 Wk Low: $44.01



 Market Capitalization (Millions $) 945
 Shares Outstanding (Millions) 19
 Employees 1,788
 Revenues (TTM) (Millions $) 920
 Net Income (TTM) (Millions $) 64
 Cash Flow (TTM) (Millions $) 42
 Capital Exp. (TTM) (Millions $) 14

Usana Health Sciences Inc

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 20 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen the direct selling distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.



   Company Address: 3838 West Parkway Blvd. Salt Lake City 84120 UT
   Company Phone Number: 954-7100   Stock Exchange / Ticker: NYSE USNA
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
NUS   -1.53%    
• View Complete Report
   



Usana Health Sciences Inc

Usana Health Sciences Inc Sees Profits Surge Despite Revenue Dip

Despite a slight decrease in revenue during the October to December 2023 period, Usana Health Sciences Inc (USNA) managed to raise its earnings per share (EPS), showing significant growth in profit. The company reported a surge of 30.06% in profit per share to $0.87, while revenue fell by -2.722% to $221.76 million year on year.
Comparing these results with the prior financial reporting period, Usana Health Sciences Inc demonstrated impressive growth. EPS soared from $0.59 per share, and revenue advanced by 4.195% from $212.84 million. This shows that the company is continuing to increase its profitability, even in the face of slightly lower revenue.
Furthermore, Usana Health Sciences Inc highlighted its improving profit margins, with net margin rising to 7.56% and operating margin edging up to 10.92% during the October to December 2023 period. These figures indicate the company's ability to control costs and maximize its profitability.

Usana Health Sciences Inc

Usana Health Sciences Inc Struggles as Revenue Regresses in Third Quarter of 2023 Earnings Season

My Experience and Analysis of Usana Health Sciences Inc's Financial Results
As a financial analyst and avid follower of the stock market, I have closely examined the latest financial results of Usana Health Sciences Inc and I am here to provide some insight into what these numbers could mean for the company and its shareholders.
In the fiscal third quarter of 2023, Usana Health Sciences Inc experienced a significant decline in income. The company's income fell by -24.36% to $0.59 per share compared to $0.78 per share a year ago. This is certainly a cause for concern, as investors always hope to see consistent growth in a company's income. Additionally, the income also faded by -33.71% from $0.89 per share from the preceding financial reporting period.

Usana Health Sciences Inc

Usana Health Sciences Inc Faces Bleak Future as Revenue Plummets in Q2 2023



The latest financial report from Usana Health Sciences Inc paints a concerning picture for the company's performance. Both revenue and net income have witnessed a significant decline, causing investors to raise concerns about the stock's future prospects. In this article, we analyze the key figures from the company's recent fiscal period and shed light on the challenges faced by Usana Health Sciences Inc.
Revenue Plummets:
During the most recent fiscal period, Usana Health Sciences Inc's revenue suffered a substantial decline of 12.823% year on year. Comparing the figures from the same three months a year earlier, revenue decreased from $272.87 million to $237.88 million. This downward trend indicates a potential struggle in maintaining consistent financial growth.

Usana Health Sciences Inc

USANA Health Sciences Boosts Revenues by 6.455%, Showcasing Stellar Performance in Q1 2023

USANA Health Sciences Inc, a global nutritional company headquartered in Utah, reported impressive financial results for the first quarter of 2023. The company saw a revenue increase of 6.455% to $248.36 million, compared to $233.30 million during the same time period in the previous year.
Earnings per share (EPS) also showed a significant increase, jumping by 21.79% to $0.95, compared to $0.78 in the prior year reporting period. Revenue advanced by 8.949% from the previous period, while EPS soared by 42.77% from $0.67 per share.
The company's net earnings also showed year-on-year growth, increasing by 23.14% from $14.929 million in the first quarter of 2022 to $18.383 million in the first quarter of 2023.
USANA Health Sciences Inc accredited its improving profit margins for these impressive results. The company's net margin rose to 7.4%, and operating margin edged up to 10.81%. While operating earnings only improved by 18.63% to $26.845 million, these margins suggest a strong performance in the long run.






 

Usana Health Sciences Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Usana Health Sciences Inc does not provide revenue guidance.

Earnings Outlook
Usana Health Sciences Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com